A detailed history of Coppell Advisory Solutions LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Coppell Advisory Solutions LLC holds 242 shares of MRNA stock, worth $14,781. This represents 0.0% of its overall portfolio holdings.

Number of Shares
242
Previous 171 41.52%
Holding current value
$14,781
Previous $17 Million 68.99%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 15, 2024

BUY
$101.21 - $166.61 $7,185 - $11,829
71 Added 41.52%
242 $28.7 Million
Q4 2023

Feb 14, 2024

BUY
$69.51 - $104.43 $7,646 - $11,487
110 Added 180.33%
171 $17 Million
Q3 2023

Nov 14, 2023

SELL
$96.41 - $126.61 $2,603 - $3,418
-27 Reduced 30.68%
61 $11 Million
Q2 2023

Aug 17, 2023

BUY
$118.5 - $160.53 $10,428 - $14,126
88 New
88 $10.7 Million
Q1 2023

May 19, 2023

SELL
$135.66 - $197.02 $8,275 - $12,018
-61 Closed
0 $0
Q4 2022

May 19, 2023

BUY
$118.38 - $210.04 $7,221 - $12,812
61 New
61 $11 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $23.9B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Coppell Advisory Solutions LLC Portfolio

Follow Coppell Advisory Solutions LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Coppell Advisory Solutions LLC, based on Form 13F filings with the SEC.

News

Stay updated on Coppell Advisory Solutions LLC with notifications on news.